The cancer stem cell niche-there goes the neighborhood?

被引:206
作者
Cabarcas, Stephanie M. [1 ]
Mathews, Lesley A. [1 ]
Farrar, William L. [1 ]
机构
[1] NIH, Canc Stem Cell Sect, Lab Canc Prevent, Ctr Canc Res, Frederick, MD USA
基金
美国国家卫生研究院;
关键词
cancer stem cell; niche; microenvironment; inflammation; hypoxia; angiogenesis; vascular niche; EMT; tumor dormancy; HUMAN EMBRYONIC STEM; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; SINGLE-MOUSE BLASTOMERES; PATHWAY INHIBITOR TFPI; TISSUE FACTOR PATHWAY; PROSTATE-CANCER; SELF-RENEWAL; HUMAN BREAST; ANTICANCER THERAPY;
D O I
10.1002/ijc.26312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The niche is the environment in which stem cells reside and is responsible for the maintenance of unique stem cell properties such as self-renewal and an undifferentiated state. The heterogeneous populations which constitute a niche include both stem cells and surrounding differentiated cells. This network of heterogeneity is responsible for the control of the necessary pathways that function in determining stem cell fate. The concept that cancer stem cells, a subpopulation of cells responsible for tumor initiation and formation, reside in their own unique niche is quickly evolving and it is of importance to understand and identify the processes occurring within this environment. The necessary intrinsic pathways that are utilized by this cancer stem cell population to maintain both self-renewal and the ability to differentiate are believed to be a result of the environment where cancer stem cells reside. The ability of a specific cancer stem cell niche to provide the environment in which this population can flourish is a critical aspect of cancer biology that mandates intense investigation. This review focuses on current evidence demonstrating that homeostatic processes such as inflammation, epithelial to mesenchymal transition, hypoxia and angiogenesis contribute to the maintenance and control of cancer stem cell fate by providing the appropriate signals within the microenvironment. It is necessary to understand the key processes occurring within this highly specialized cancer stem cell niche to identify potential therapeutic targets that can serve as the basis for development of more effective anticancer treatments.
引用
收藏
页码:2315 / 2327
页数:13
相关论文
共 135 条
[1]   Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network [J].
Aiden, Aviva Presser ;
Rivera, Miguel N. ;
Rheinbay, Esther ;
Ku, Manching ;
Coffman, Erik J. ;
Truong, Thanh T. ;
Vargas, Sara O. ;
Lander, Eric S. ;
Haber, Daniel A. ;
Bernstein, Bradley E. .
CELL STEM CELL, 2010, 6 (06) :591-602
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   Molecular mechanisms underlying tumor dormancy [J].
Almog, Nava .
CANCER LETTERS, 2010, 294 (02) :139-146
[4]   A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma [J].
Balasenthil, Seetharaman ;
Chen, Nanyue ;
Lott, Steven T. ;
Chen, Jinyun ;
Carter, Jennifer ;
Grizzle, William E. ;
Frazier, Marsha L. ;
Sen, Subrata ;
Killary, Ann McNeill .
CANCER PREVENTION RESEARCH, 2011, 4 (01) :137-149
[5]   Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor [J].
Bao, Shideng ;
Wu, Qiulian ;
Sathornsumetee, Sith ;
Hao, Yueling ;
Li, Zhizhong ;
Hjelmeland, Anita B. ;
Shi, Oing ;
McLendon, Roger E. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2006, 66 (16) :7843-7848
[6]   IL-6: Insights into novel biological activities [J].
Barton, BE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (01) :16-20
[7]   Characterization of the CXCR4 signaling in pancreatic cancer cells [J].
Billadeau D.D. ;
Chatterjee S. ;
Bramati P. ;
Sreekumar R. ;
Shah V. ;
Hedin K. ;
Urrutia R. .
Journal of Gastrointestinal Cancer, 2006, 37 (4) :110-119
[8]   Cadherins as novel targets for anti-cancer therapy [J].
Blaschuk, Orest W. ;
Devemy, Emmanuelle .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 625 (1-3) :195-198
[9]   CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers [J].
Burger, J. A. ;
Peled, A. .
LEUKEMIA, 2009, 23 (01) :43-52
[10]   Twist-ing Cell Fate: Mechanistic Insights Into the Role of Twist in Lineage Specification/Differentiation and Tumorigenesis [J].
Cakouros, D. ;
Raices, R. M. ;
Gronthos, S. ;
Glackin, C. A. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 110 (06) :1288-1298